• Company
    • About Us
    • Partnerships
    • Board & Teams
  • Technologies
    • Natural Killer Cells
    • Mesenchymal Stromal Cells
  • Pipeline
  • News
    • Press Releases
    • In The Press
    • Articles
  • Careers
  • Contact
Menu
  • Company
    • About Us
    • Partnerships
    • Board & Teams
  • Technologies
    • Natural Killer Cells
    • Mesenchymal Stromal Cells
  • Pipeline
  • News
    • Press Releases
    • In The Press
    • Articles
  • Careers
  • Contact

The MedXCell Group is delighted to announce that Prof. Guillaume Cartron (MD, Ph.D.) has joined its team as Scientific and Clinical Advisor

Montreux, Switzerland | March 1st, 2021 – MedXCell SA, a Swiss biotech portfolio company dedicated to transforming healthcare through the development and production of innovative,

Read More »

MedXCell SA selected to participate in the sixth edition of the pre-IPO program TechShare organized by Euronext

Montreux, Switzerland | January 21, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible

Read More »
Page1 Page2

Montreux, CH – Montpellier, FR – Cambridge MA, USA

Linkedin

This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider

© All rights reserved 2021 – MedXCell SA